Drug Resistance, Viral

Pathogenesis and Immunity
Dual Selection Pressure by Drugs and HLA Class I-Restricted Immune Responses on Human Immunodeficiency Virus Type 1 Protease
Sandra M. Mueller, Birgit Schaetz, Kathrin Eismann, Silke Bergmann, Michael Bauerle, Matthias Schmitt-Haendle, Hauke Walter, Barbara Schmidt, Klaus Korn, Heinrich Sticht, Bernd Spriewald, Ellen G. Harrer, Thomas Harrer
Minireview
Cyclophilin A, TRIM5, and Resistance to Human Immunodeficiency Virus Type 1 Infection
Jeremy Luban
Vaccines and Antiviral Agents
Human Immunodeficiency Virus Type 1 Resistance to the Small Molecule Maturation Inhibitor 3-O-(3′,3′-Dimethylsuccinyl)-Betulinic Acid Is Conferred by a Variety of Single Amino Acid Substitutions at the CA-SP1 Cleavage Site in Gag
Jing Zhou, Chin Ho Chen, Christopher Aiken
Vaccines and Antiviral Agents
In Vitro Resistance to the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PA-457 (Bevirimat)
Catherine S. Adamson, Sherimay D. Ablan, Ioana Boeras, Ritu Goila-Gaur, Ferri Soheilian, Kunio Nagashima, Feng Li, Karl Salzwedel, Michael Sakalian, Carl T. Wild, Eric O. Freed
Vaccines and Antiviral Agents
Cidofovir Resistance in Vaccinia Virus Is Linked to Diminished Virulencein Mice
Graciela Andrei, Don B. Gammon, Pierre Fiten, Erik De Clercq, Ghislain Opdenakker, Robert Snoeck, David H. Evans
Vaccines and Antiviral Agents
Mutational Pathways, Resistance Profile, and Side Effects of Cyanovirin Relative to Human Immunodeficiency Virus Type 1 Strains with N-Glycan Deletions in Their gp120 Envelopes
Jan Balzarini, Kristel Van Laethem, Willy J. Peumans, Els J. M. Van Damme, Anders Bolmstedt, Federico Gago, Dominique Schols
Vaccines and Antiviral Agents
Importance of Neuraminidase Active-Site Residues to the Neuraminidase Inhibitor Resistance of Influenza Viruses
Hui-Ling Yen, Erich Hoffmann, Garry Taylor, Christoph Scholtissek, Arnold S. Monto, Robert G. Webster, Elena A. Govorkova
Vaccines and Antiviral Agents
Role of the Envelope Genetic Context in the Development of Enfuvirtide Resistance in Human Immunodeficiency Virus Type 1-Infected Patients
Béatrice Labrosse, Laurence Morand-Joubert, Armelle Goubard, Séverine Rochas, Jean-Louis Labernardière, Jerôme Pacanowski, Jean-Luc Meynard, Allan J. Hance, François Clavel, Fabrizio Mammano
Vaccines and Antiviral Agents
Involvement of Novel Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutations in the Regulation of Resistance to Nucleoside Inhibitors
Valentina Svicher, Tobias Sing, Maria Mercedes Santoro, Federica Forbici, Fátima Rodríguez-Barrios, Ada Bertoli, Niko Beerenwinkel, Maria Concetta Bellocchi, Federigo Gago, Antonella d'Arminio Monforte, Andrea Antinori, Thomas Lengauer, Francesca Ceccherini-Silberstein, Carlo Federico Perno
Vaccines and Antiviral Agents
Fitness Comparison of Thymidine Analog Resistance Pathways in Human Immunodeficiency Virus Type 1
Zixin Hu, Françoise Giguel, Hiroyu Hatano, Patrick Reid, Jing Lu, Daniel R. Kuritzkes

Main menu

User menu

Search

Drug Resistance, Viral

Pages